Amyris Analyst Ratings
Amyris Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/10/2022 | — | JP Morgan | Downgrades | Neutral → Underweight | |
11/09/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
09/19/2022 | 164.03% | Piper Sandler | $2.5 → $4 | Maintains | Neutral |
08/10/2022 | 32.01% | Roth Capital | → $2 | Downgrades | Buy → Neutral |
06/24/2022 | — | JP Morgan | Initiates Coverage On | → Neutral | |
05/25/2022 | 65.02% | Piper Sandler | → $2.5 | Initiates Coverage On | → Neutral |
08/06/2021 | 1352.15% | Roth Capital | $25 → $22 | Maintains | Buy |
08/06/2021 | 1616.17% | Oppenheimer | $25 → $26 | Maintains | Outperform |
08/06/2021 | 1880.2% | HC Wainwright & Co. | $35 → $30 | Maintains | Buy |
06/01/2021 | 1220.13% | HSBC | → $20 | Initiates Coverage On | → Buy |
03/03/2021 | 2078.22% | Roth Capital | $20 → $33 | Maintains | Buy |
03/03/2021 | 2210.23% | HC Wainwright & Co. | $11 → $35 | Maintains | Buy |
02/26/2021 | 1220.13% | Roth Capital | → $20 | Initiates Coverage On | → Buy |
01/06/2021 | 494.06% | Cowen & Co. | → $9 | Upgrades | Market Perform → Outperform |
11/25/2020 | 230.03% | Cowen & Co. | → $5 | Initiates Coverage On | → Market Perform |
11/25/2020 | 121.12% | Jefferies | → $3.35 | Initiates Coverage On | → Buy |
12/12/2019 | 428.05% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
03/20/2018 | 560.07% | B. Riley Securities | $8 → $10 | Maintains | Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
2022年11月10日 | - | 摩根大通 | 評級下調 | 中性→減持 | |
11/09/2022 | - | 奧本海默 | 評級下調 | 超越→表現 | |
2022/09/19 | 164.03% | 派珀·桑德勒 | $2.5→$4 | 維護 | 中性 |
2022年08月10日 | 32.01% | 羅斯資本 | →$2 | 評級下調 | 購買→中性 |
2022/06/24 | - | 摩根大通 | 開始承保 | →中性 | |
2022年05月25日 | 65.02% | 派珀·桑德勒 | →$2.5 | 開始承保 | →中性 |
08/06/2021 | 1352.15% | 羅斯資本 | $25→$22 | 維護 | 買 |
08/06/2021 | 1616.17% | 奧本海默 | $25→$26 | 維護 | 跑贏大盤 |
08/06/2021 | 1880.2% | HC Wainwright公司 | $35→$30 | 維護 | 買 |
06/01/2021 | 1220.13% | 匯豐銀行 | →$20 | 開始承保 | →購買 |
03/03/2021 | 2078.22% | 羅斯資本 | $20→$33 | 維護 | 買 |
03/03/2021 | 2210.23% | HC Wainwright公司 | $11→$35 | 維護 | 買 |
02/26/2021 | 1220.13% | 羅斯資本 | →$20 | 開始承保 | →購買 |
01/06/2021 | 494.06% | 考恩公司 | →$9 | 升級 | 市場表現優於→ |
11/25/2020 | 230.03% | 考恩公司 | →$5 | 開始承保 | →市場表現 |
11/25/2020 | 121.12% | 傑富瑞 | →$3.35 | 開始承保 | →購買 |
2019年12月12日 | 428.05% | 奧本海默 | →$8 | 開始承保 | →跑贏大盤 |
2018年3月20日 | 560.07% | B.萊利證券 | $8→$10 | 維護 | 買 |
What is the target price for Amyris (AMRS)?
Amyris(AMRS)的目標價是多少?
The latest price target for Amyris (NASDAQ: AMRS) was reported by JP Morgan on November 10, 2022. The analyst firm set a price target for $0.00 expecting AMRS to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
摩根大通於2022年11月10日報道了AMRIS(納斯達克代碼:AMRS)的最新目標價。這家分析公司將目標價定為0.00美元,預計AMR將在12個月內下降(跌幅可能為-100.00%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Amyris (AMRS)?
Amyris(AMRS)的最新分析師評級是多少?
The latest analyst rating for Amyris (NASDAQ: AMRS) was provided by JP Morgan, and Amyris downgraded their underweight rating.
納斯達克(JP Morgan)對Amyris(股票代碼:AMRS)的最新分析師評級是由摩根大通提供的,Amyris下調了其減持評級。
When is the next analyst rating going to be posted or updated for Amyris (AMRS)?
Amyris(AMRS)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amyris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amyris was filed on November 10, 2022 so you should expect the next rating to be made available sometime around November 10, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Amyris的高管和客戶交談,以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Amyris的上一次評級是在2022年11月10日提交的,所以你應該預計下一次評級將在2023年11月10日左右的某個時候公佈。
Is the Analyst Rating Amyris (AMRS) correct?
分析師對Amyris(AMRS)的評級正確嗎?
While ratings are subjective and will change, the latest Amyris (AMRS) rating was a downgraded with a price target of $0.00 to $0.00. The current price Amyris (AMRS) is trading at is $1.52, which is out of the analyst's predicted range.
雖然評級是主觀的,而且會發生變化,但最新的Amyris(AMRS)評級被下調,目標價在0.00美元至0.00美元之間。目前Amyris的交易價格為1.52美元,超出了分析師的預期區間。